Drug Induced Liver Injury (DILI)
Drugs are an important reason for liver injury. Liver injury occurs because of use of more than 900 drugs, toxins, and herbs and drugs represent 20 – 40 percent of all instances of fulminant liver failure. Around 75 percent of the idiosyncratic drug reactions will leads to transplantation of liver or even death sometimes. Drug Hepatotoxicity is the most common reason for withdrawal of an approved drug. Doctors must be vigilant in recognizing drug-related liver injury as because if it will be detected earlier, then it could decrease the severity of hepatotoxicity if the drug is discontinued. The illustrations of DILI are highly variable, ranging from asymptomatic elevation of liver enzymes to fulminant liver failure. Information on commonly implicated agents and a high index of suspicion are very much essential in diagnosis.
In U.S.A., around 200 cases of acute liver failure occur every year and drugs account for over 50% of them (39% are because of acetaminophen, 13% are idiosyncratic reaction because of other meds). Drugs accounts for 2-5% of cases of patients who all are hospitalized with jaundice and around 10% of all cases of acute hepatitis.
Related Conference of Drug Induced Liver Injury (DILI)
18th World Conference on Gynecology, Obstetrics and Women Health
26th International Conference on Gastroenterology and Hepatology
25th International Conference on Gastroenterology and Digestive Disorders
Drug Induced Liver Injury (DILI) Conference Speakers
Recommended Sessions
- Drug Induced Liver Injury (DILI)
- HCV/HIV Coinfection
- Hepatitis B and Other Viral Hepatitis
- Liver Cancer
- Liver Fibrosis
- Liver Growth and Repair
- Liver Imaging Modalities
- Liver Inflammation and Immunology
- Liver Transplantation and Liver Surgery (Experimental & Clinical)
- Molecular and Cellular Biology
- Other Liver Diseases
- Pediatric Hepatology
- Viral Hepatitis C
Related Journals
Are you interested in
- Abdominal & Primary Care - Gastro Congress 2026 (UK)
- Adolescent Gynecology and Reproductive Development - Gynecology2026 (Spain)
- Advances in Assisted Reproductive Technologies - Gynecology2026 (Spain)
- Advances in Maternal-Fetal Medicine - Gynecology2026 (Spain)
- Advances in Medical Imaging - Gastrosummit 2027 (France)
- Advances in Neonatal and Perinatal Medicine - Gynecology2026 (Spain)
- Advances in Obstetric and Gynecologic Imaging - Gynecology2026 (Spain)
- Advances in Prenatal and Postnatal Care - Gynecology2026 (Spain)
- Artificial Intelligence and Digital Transformation in Women’s Healthcare - Gynecology2026 (Spain)
- Celiac Disease - Gastrosummit 2027 (France)
- Celiac Diseases - Gastro Congress 2026 (UK)
- Colorectal Diseases - Gastrosummit 2027 (France)
- Contraceptive Technologies and Family Planning - Gynecology2026 (Spain)
- Covid-19 effects on gastroenterology practices - Gastro Congress 2026 (UK)
- Digestive System Cancers - Gastrosummit 2027 (France)
- Endometriosis and Pelvic Pain Management - Gynecology2026 (Spain)
- Esophageal and Gastric Disease - Gastro Congress 2026 (UK)
- Esophageal Disorders - Gastrosummit 2027 (France)
- Esophageal Disorders - Gastrosummit 2027 (France)
- Future Trends in Gynecology and Women’s Health Research - Gynecology2026 (Spain)
- Gastric Diseases and Peptic Ulcers - Gastrosummit 2027 (France)
- Gastric Diseases and Peptic Ulcers - Gastrosummit 2027 (France)
- Gastroenterology - Gastro Congress 2026 (UK)
- Gastrointestinal Bleeding - Gastrosummit 2027 (France)
- Gastrointestinal Cancer - Gastro Congress 2026 (UK)
- Gastrointestinal Endoscopy and Surgery - Gastro Congress 2026 (UK)
- Gastrointestinal Pathology - Gastro Congress 2026 (UK)
- Gastrointestinal Pharmacology - Gastrosummit 2027 (France)
- Gastrointestinal Pharmacotherapy - Gastro Congress 2026 (UK)
- Gastrointestinal Surgery - Gastrosummit 2027 (France)
- Genetics and Reproductive Medicine - Gynecology2026 (Spain)
- Geriatric Gastroenterology - Gastrosummit 2027 (France)
- Global Women’s Health and Reproductive Rights - Gynecology2026 (Spain)
- Gynecologic Oncology and Cancer Prevention - Gynecology2026 (Spain)
- Hepatitis - Gastro Congress 2026 (UK)
- Hepatology - Gastro Congress 2026 (UK)
- Inflammatory Bowel Disease (IBD) - Gastrosummit 2027 (France)
- Innovations in Gynecologic and Obstetric Pharmacology - Gynecology2026 (Spain)
- Innovations in Midwifery and Safe Childbirth Practices - Gynecology2026 (Spain)
- Liver Diseases and Hepatology - Gastrosummit 2027 (France)
- Liver Transplantation - Gastrosummit 2027 (France)
- Maternal Mental Health and Postpartum Wellbeing - Gynecology2026 (Spain)
- Maternal Nutrition and Lactation Science - Gynecology2026 (Spain)
- Menopause and Healthy Aging in Women - Gynecology2026 (Spain)
- Menstrual Health and Disorders - Gynecology2026 (Spain)
- Microbiota - Gastro Congress 2026 (UK)
- Minimally Invasive Gynecologic Surgery - Gynecology2026 (Spain)
- Nutrition in Digestive Health - Gastrosummit 2027 (France)
- Paediatric Gastroenterology - Gastro Congress 2026 (UK)
- Pancreatic and biliary disease - Gastro Congress 2026 (UK)
- Pancreatic Diseases - Gastrosummit 2027 (France)
- Pancreaticobiliary Disorders - Gastrosummit 2027 (France)
- Pediatric Gastroenterology - Gastrosummit 2027 (France)
- Polycystic Ovary Syndrome and Hormonal Disorders - Gynecology2026 (Spain)
- Precision Medicine in Digestive Diseases - Gastrosummit 2027 (France)
- Preventive Gynecology and Public Health - Gynecology2026 (Spain)
- Reproductive Endocrinology and Infertility - Gynecology2026 (Spain)
- Sexual and Reproductive Health Education - Gynecology2026 (Spain)
- Small Bowel and Colonic Disease - Gastro Congress 2026 (UK)
- Urogynecology and Pelvic Floor Disorders - Gynecology2026 (Spain)
- Viral Hepatitis - Gastrosummit 2027 (France)
